돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 634861생성일: 2026년 10월 25일

Acetone → N-[4-(2-methyl-2H-tetrazol-5-yl)phenylmethyl]-4-[bis(4-trifluoromethoxyphenyl)hydroxymethyl]piperidine

https://huagongshe.com/reaction/634861

반응식

참여 물질

역할이름HCID투입량
반응물AcetoneHCID 180—
반응물DiisopropylethylamineHCID 81531—
반응물5-(4-Bromomethylphenyl)-2-methyl-2H-tetrazoleHCID 589329—
반응물4-[Bis(4-trifluoromethoxyphenyl)hydroxymethyl]piperidineHCID 19040926—
용매Dimethyl SulfoxideHCID 679—
용매DichloromethaneHCID 6344—
생성물N-[4-(2-methyl-2H-tetrazol-5-yl)phenylmethyl]-4-[bis(4-trifluoromethoxyphenyl)hydroxymethyl]piperidineHCID 1551518532.9%

반응 단계

This compound was prepared in a manner analogous to that of Step D of Example 4, with 0.3 gram (0.001 mole) of 4-(2-methyl-2H-tetrazol-5-yl)phenylmethyl bromide, 0.5 gram (0.001 mole) of 4-[bis(4-trifluoromethoxyphenyl)hydroxymethyl]piperidine (prepared as in Step C of Example 4), and 0.6 gram (0.004 mole) of N,N-diisopropylethylamine in about 5 mL of dimethyl sulfoxide as reagents. The crude reaction product was subjected to column chromatography on silica gel, with 3:7 acetone:methylene chloride as the eluant. The product-containing fractions were combined and concentrated under reduced pressure, yielding about 0.2 gram of N-[4-(2-methyl-2H-tetrazol-5-yl)phenylmethyl]-4-[bis(4-trifluoromethoxyphenyl)hydroxymethyl]piperidine. The NMR spectrum was consistent with the proposed structure.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US06184234B2
출처 데이터셋uspto-grants-2001_02
ORD IDord-e2fcd7fe246e4e6298eb9ecad3759803
출처 메모uspto-grants-2001_02